PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsQuinidine polygalacturonate
Quinidine polygalacturonate
Cardioquin, Nuedexta, Quinidine (quinidine polygalacturonate) is a small molecule pharmaceutical. Quinidine polygalacturonate was first approved as Quinaglute on 1982-01-01. It is used to treat atrial fibrillation, atrial flutter, and cardiac arrhythmias in the USA. It has been approved in Europe to treat neurobehavioral manifestations.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
nervous system diseasesD009422
cardiovascular diseasesD002318
signs and symptoms pathological conditionsD013568
behavior and behavior mechanismsD001520
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Quinidine polygalacturonate
Tradename
Company
Number
Date
Products
CARDIOQUINPharmaceutical Research Associates IncN-011642 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
quinidine gluconateANDA2024-08-27
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Dextromethorphan Hydrobromide / Quinidine Sulfate, Nuedexta, Avanir Pharms
76592822026-08-13U-1093
82274842023-07-17U-1093
ATC Codes
C: Cardiovascular system drugs
C01: Cardiac therapy drugs
C01B: Antiarrhythmics, class i and iii
C01BA: Antiarrhythmics, class ia
C01BA01: Quinidine
C01BA51: Quinidine, combinations excl. psycholeptics
C01BA71: Quinidine, combinations with psycholeptics
HCPCS
No data
Clinical
Clinical Trials
67 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pseudobulbar palsyD020828EFO_1001131134
Alzheimer diseaseD000544EFO_0000249F03112
StrokeD020521EFO_0000712I63.911
Traumatic brain injuriesD000070642S0611
Brain injuriesD001930S06.911
DementiaD003704EFO_0003862F0311
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SclerosisD012598112
Amyotrophic lateral sclerosisD000690EFO_0000253G12.2122
PainD010146EFO_0003843R5211
Diabetic neuropathiesD003929EFO_100078311
Motor neuron diseaseD016472EFO_0003782G12.211
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SchizophreniaD012559EFO_0000692F2011
DepressionD003863F33.911
Treatment-resistant depressive disorderD06121811
Major depressive disorderD003865EFO_0003761F2211
Depressive disorderD003866EFO_1002014F32.A11
Parkinson diseaseD010300EFO_0002508G2011
DyskinesiasD020820G2411
Psychomotor agitationD01159511
Multiple sclerosisD009103EFO_0003885G3511
NeuralgiaD009437EFO_000943011
Show 2 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients44
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameQuinidine polygalacturonate
INN
Description
Quinidine is a cinchona alkaloid consisting of cinchonine with the hydrogen at the 6-position of the quinoline ring substituted by methoxy. It has a role as an alpha-adrenergic antagonist, an antimalarial, an anti-arrhythmia drug, a sodium channel blocker, a muscarinic antagonist, a potassium channel blocker, a P450 inhibitor, an EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor, an EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor and a drug allergen. It derives from a hydride of a cinchonan.
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID56-54-2
RxCUI9068
ChEMBL IDCHEMBL1201486
ChEBI ID
PubChem CID441074
DrugBankDB00908
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 18 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
5,754 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use